🇺🇸 FDA
Patent

US 8182807

Method for inhibiting reperfusion injury in the brain

granted A61KA61K31/07A61K31/355

Quick answer

US patent 8182807 (Method for inhibiting reperfusion injury in the brain) held by Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center
Grant date
Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/07, A61K31/355, A61K31/375, A61K38/446